From the record · 2026-06-13

A study reported on the use of in vivo CRISPR gene editing with Lonvoguran Ziclumeran to treat hereditary angioedema.

Items older than 7 days — their verdicts, sources and coverage history — are part of the Azimuth Daily record and available to signed-in readers.